Delaware
|
11-2481903
|
(State
or other jurisdiction of incorporation or
organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
1450
Broadway, New York, NY
|
10018
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Part
I.
|
Financial
Information
|
Page
No.
|
|
|
|
|
|
Item
1.
|
Financial
Statements
|
|
|
|
Unaudited
Condensed Consolidated Balance Sheets - June 30, 2007 and December
31,
2006
|
3
|
|
|
Unaudited
Condensed Consolidated Income Statements - Three and Six Months Ended
June
30, 2007 and 2006
|
4
|
|
|
Unaudited
Condensed Consolidated Statement of Stockholders' Equity - Six Months
Ended June 30, 2007
|
5
|
|
|
Unaudited
Condensed Consolidated Statements of Cash Flows - Six Months Ended
June
30, 2007 and 2006
|
6
|
|
|
Notes
to Unaudited Condensed Consolidated Financial Statements
|
8
|
|
|
|
|
|
Item
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
17
|
|
|
|
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
21
|
|
|
|
|
|
Item
4.
|
Controls
and Procedures
|
21
|
|
|
|
|
|
Part
II.
|
Other
Information
|
22
|
|
|
|
|
|
Item
1.
|
Legal
Proceedings
|
22
|
|
Item
1A.
|
Risk
Factors
|
22
|
|
Item
5
|
Other
Information
|
24
|
|
Item
6.
|
Exhibits
|
24
|
|
|
|
||
Signatures
|
|
25
|
|
June
30,
|
December
31,
|
|||||
|
2007
|
2006
|
|||||
Assets
|
(unaudited)
|
|
|||||
Current
Assets:
|
|
|
|||||
Cash
and cash equivalents (including restricted cash of $1,029 in 2007
and
$4,268 in 2006)
|
$
|
80,881
|
$
|
77,840
|
|||
Marketable
securities1
|
196,400
|
-
|
|||||
Accounts
receivable, net of reserve for doubtful accounts of $2,581 in 2007
and
$1,633 in 2006
|
23,292
|
14,548
|
|||||
Due
from affiliate
|
190
|
297
|
|||||
Promissory
note receivable
|
1,000
|
1,000
|
|||||
Deferred
income tax assets
|
11,545
|
3,440
|
|||||
Prepaid
advertising and other
|
5,479
|
2,704
|
|||||
Total
Current Assets
|
318,787
|
99,829
|
|||||
Property
and equipment:
|
|||||||
Furniture,
fixtures and equipment
|
2,809
|
2,769
|
|||||
Less:
Accumulated depreciation and amortization
|
(1,463
|
)
|
(1,385
|
)
|
|||
|
1,346
|
1,384
|
|||||
Other
Assets:
|
|||||||
Restricted
cash
|
13,828
|
11,659
|
|||||
Goodwill
|
96,511
|
93,593
|
|||||
Trademarks
and other intangibles, net
|
746,908
|
467,688
|
|||||
Deferred
financing costs, net
|
7,847
|
3,355
|
|||||
Non-current
deferred income tax assets
|
27,933
|
17,970
|
|||||
Other
|
4,966
|
5,574
|
|||||
|
897,993
|
599,839
|
|||||
Total
Assets
|
$
|
1,218,126
|
$
|
701,052
|
|||
|
|||||||
Liabilities
and Stockholders' Equity
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable and accrued expenses
|
$
|
6,957
|
$
|
7,043
|
|||
Accounts
payable, subject to litigation
|
4,886
|
4,886
|
|||||
Deferred
revenue
|
4,325
|
1,644
|
|||||
Current
portion of long-term debt
|
25,459
|
22,132
|
|||||
Total
current liabilities
|
41,627
|
35,705
|
|||||
|
|||||||
Deferred
income taxes
|
65,433
|
59,054
|
|||||
Long-term
debt, less current maturities
|
621,660
|
140,676
|
|||||
Long
term deferred revenue
|
400
|
160
|
|||||
Total
Liabilities
|
729,120
|
235,595
|
|||||
|
|||||||
Contingencies
and commitments
|
|||||||
|
|||||||
Stockholders'
Equity
|
|||||||
Common
stock, $.001 par value
-
shares authorized 75,000; shares issued 56,771 and 56,227
respectively
|
57
|
57
|
|||||
Additional
paid-in capital
|
464,894
|
468,881
|
|||||
Retained
earnings (deficit)
|
24,722
|
(2,814
|
)
|
||||
Less:
Treasury stock - 198 shares at cost
|
(667
|
)
|
(667
|
)
|
|||
Total
stockholders' equity
|
489,006
|
465,457
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
1,218,126
|
$
|
701,052
|
|
Three
Months Ended June 30,
|
Six
Months Ended June 30,
|
|||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||
|
|
|
|
|
|||||||||
Licensing
and commission revenue
|
$
|
39,071
|
$
|
18,409
|
$
|
69,912
|
$
|
31,678
|
|||||
|
|||||||||||||
Selling,
general and administrative expenses
|
9,011
|
6,817
|
16,730
|
11,501
|
|||||||||
Special
charges
|
331
|
712
|
1,094
|
1,268
|
|||||||||
|
|||||||||||||
Operating
income
|
29,729
|
10,880
|
52,088
|
18,909
|
|||||||||
|
|||||||||||||
Other
expenses:
|
|||||||||||||
Interest
expense
|
7,872
|
3,073
|
11,407
|
5,178
|
|||||||||
Interest
income
|
(959
|
)
|
(191
|
)
|
(1,872
|
)
|
(352
|
)
|
|||||
Interest
expense - net
|
6,913
|
2,882
|
9,535
|
4,826
|
|||||||||
|
|||||||||||||
Income
before income taxes
|
22,816
|
7,998
|
42,553
|
14,083
|
|||||||||
|
|||||||||||||
Provision
(benefit) for income taxes
|
8,027
|
(347
|
)
|
15,017
|
(1,619
|
)
|
|||||||
|
|||||||||||||
Net
income
|
$
|
14,789
|
$
|
8,345
|
$
|
27,536
|
$
|
15,702
|
|||||
|
|||||||||||||
Earnings
per share:
|
|||||||||||||
Basic
|
$
|
0.26
|
$
|
0.22
|
$
|
0.49
|
$
|
0.42
|
|||||
|
|||||||||||||
Diluted
|
$
|
0.24
|
$
|
0.19
|
$
|
0.45
|
$
|
0.37
|
|||||
|
|||||||||||||
|
|||||||||||||
Weighted
average number of common shares outstanding:
|
|||||||||||||
Basic
|
56,625
|
38,680
|
56,451
|
37,208
|
|||||||||
|
|||||||||||||
Diluted
|
61,364
|
44,712
|
61,241
|
42,872
|
|
|
|
Additional
|
Retained
|
|
|
|||||||||||||
|
Common
Stock
|
Paid
- in
|
Earnings/
|
Treasury
|
|
||||||||||||||
|
Shares
|
Amount
|
Capital
|
(Deficit)
|
Stock
|
Total
|
|||||||||||||
Balance
at January 1, 2007
|
56,227
|
$
|
57
|
$
|
468,881
|
$
|
(2,814
|
)
|
$
|
(667
|
)
|
$
|
465,457
|
||||||
Warrants
issued to non-employee related to the acquisition of
Danksin®
|
-
|
-
|
2,260
|
-
|
-
|
2,260
|
|||||||||||||
Warrants
issued to non-employee related to the acquisition of
Rocawear®
|
-
|
-
|
2,671
|
-
|
-
|
2,671
|
|||||||||||||
Common
stock issued to non-employee related to the acquisition of
Danksin®
|
13
|
-
|
241
|
-
|
-
|
241
|
|||||||||||||
Common
stock issued to non-employee related to the acquisition of
Rocawear®
|
12
|
-
|
255
|
-
|
-
|
255
|
|||||||||||||
Exercise
of stock options and warrants
|
505
|
-
|
1,130
|
-
|
-
|
1,130
|
|||||||||||||
Stock
option compensation
|
-
|
-
|
135
|
-
|
-
|
135
|
|||||||||||||
Tax
benefit of stock option exercise
|
-
|
-
|
928
|
-
|
-
|
928
|
|||||||||||||
Amortization
in connection with restricted stock
|
14
|
-
|
684
|
-
|
-
|
684
|
|||||||||||||
Expenses
related to common stock issuance
|
-
|
-
|
(184
|
)
|
-
|
-
|
(184
|
)
|
|||||||||||
Net
cost of hedge on convertible note
|
-
|
-
|
(12,107
|
)
|
-
|
-
|
(12,107
|
)
|
|||||||||||
Net
income
|
-
|
-
|
-
|
27,536
|
-
|
27,536
|
|||||||||||||
Balance
at June 30, 2007
|
56,771
|
$
|
57
|
$
|
464,894
|
$
|
24,722
|
$
|
(667
|
)
|
$
|
489,006
|
Six
Months Ended June 30,
|
|||||||
|
2007
|
|
|
2006
|
|||
|
|||||||
Cash
flows from operating activities:
|
|||||||
Net
income
|
$
|
27,536
|
$
|
15,702
|
|||
Depreciation
of property and equipment
|
78
|
101
|
|||||
Amortization
of intangibles
|
2,388
|
816
|
|||||
Amortization
of deferred financing costs
|
497
|
295
|
|||||
Loss
on sale of marketable securities
|
-
|
166
|
|||||
Provision
for doubtful accounts
|
1,137
|
625
|
|||||
Stock
option compensation
|
819
|
89
|
|||||
Accrued
interest on long-term debt
|
95
|
58
|
|||||
Deferred
income tax provision (benefit)
|
15,017
|
(4,147
|
)
|
||||
Changes
in operating assets and liabilities, net of business
acquisitions:
|
|||||||
Accounts
receivable
|
(9,881
|
)
|
(5,339
|
)
|
|||
Due
from affiliate
|
107
|
(26
|
)
|
||||
Prepaid
advertising and other
|
(3,225
|
)
|
(187
|
)
|
|||
Other
assets
|
608
|
232
|
|||||
Deferred
revenue
|
2,921
|
(2,137
|
)
|
||||
Accounts
payable and accrued expenses
|
(1,703
|
)
|
1,558
|
||||
Net
cash provided by operating activities
|
36,394
|
7,806
|
|||||
Cash
flows from investing activities:
|
|||||||
Purchases
of property and equipment
|
(40
|
)
|
(558
|
)
|
|||
Acquisition
of Mudd
|
-
|
(45,785
|
)
|
||||
Acquisition
of Danskin
|
(71,035
|
)
|
-
|
||||
Acquisition
of Rocawear
|
(205,534
|
)
|
-
|
||||
Purchase
of trademarks
|
(110
|
)
|
(829
|
)
|
|||
Purchase
of marketable securities
|
(196,400
|
)1
|
(78
|
) | |||
Net
cash used in investing activities
|
(473,119
|
)
|
(47,250
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Proceeds
from long-term debt
|
531,022
|
49,000
|
|||||
Payment
for purchase of convertible note hedge
|
(76,303
|
)
|
-
|
||||
Proceeds
from exercise of stock options and warrants
|
1,130
|
931
|
|||||
Payment
of long-term debt
|
(9,315
|
)
|
(4,528
|
)
|
|||
Payment
of expenses related to common stock issuance
|
(184
|
)
|
-
|
||||
Deferred
financing costs
|
(4,415
|
)
|
(490
|
)
|
|||
Restricted
cash - Current
|
3,239
|
(4,909
|
)
|
||||
Restricted
cash - Non Current
|
(2,169
|
)
|
(3,564
|
)
|
|||
Net
cash provided by financing activities
|
443,005
|
36,440
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
6,280
|
(3,004
|
)
|
||||
Cash
and cash equivalents, beginning of period
|
73,572
|
7,593
|
|||||
Cash
and cash equivalents, end of period
|
$
|
79,852
|
$
|
4,589
|
|||
|
|||||||
Balance
of restricted cash - Current
|
1,029
|
9,003
|
|||||
Total
cash and cash equivalents including current restricted cash, end
of
period
|
$
|
80,881
|
$
|
13,592
|
|
Six
Months Ended June 30,
|
||||||
|
2007
|
2006
|
|||||
|
|
|
|||||
Cash
paid during the period:
|
|||||||
Interest
|
$
|
10,694
|
$
|
4,157
|
|||
|
|||||||
Taxes
|
$
|
1,136
|
$
|
-
|
|
Six
Months Ended June 30,
|
||||||
|
2007
|
|
|
2006
|
|||
|
|||||||
Acquisitions:
|
|||||||
Common
stock issued
|
$
|
496
|
$
|
47,862
|
|||
Warrants
issued - acquisition cost
|
$
|
4,931
|
$
|
4,596
|
|||
|
|||||||
Issuance
of promissory note
|
$
|
-
|
$
|
750
|
|||
|
|||||||
Net
cost of hedge on convertible note
|
$
|
12,107
|
$
|
-
|
(000's
omitted except share information)
|
|
|
|||||
Cash
paid at closing to sellers
|
$
|
70,000
|
|||||
Fair
value of 12,500 shares of $.001 par value common stock, at $19.33
fair
market value per share issued as a cost of the
acquisition
|
$
|
241
|
|||||
Fair
value of 30,000 warrants ($20.18 exercise price) issued as a cost
of the
acquisition
|
284
|
||||||
Fair
value of 133,334 warrants ($8.81 exercise price) issued as a cost
of the
acquisition
|
1,976
|
||||||
Total
equity consideration
|
2,501
|
||||||
Other
estimated costs of the merger
|
1,782
|
||||||
Total
|
$
|
74,283
|
Trademarks
|
$
|
71,700
|
||
License
agreements
|
1,700
|
|||
Goodwill
|
883
|
|||
Total
allocated purchase price
|
$
|
74,283
|
(000's
omitted except share information)
|
|||||||
Cash
paid at closing to sellers
|
$
|
204,000
|
|||||
Fair
value of 12,500 shares of $.001 par value common stock, at $20.40
fair
market value per share issued as a cost of acquisition
|
255
|
||||||
Fair
value of 55,000 warrants ($20.40 exercise price) issued as a cost
of the
acquisition
|
562
|
||||||
Fair
value of 133,334 warrants ($8.81 exercise price) issued as a cost
of the
acquisition
|
2,109
|
||||||
Total
equity consideration
|
2,926
|
||||||
Other
estimated costs of the merger
|
3,208
|
||||||
Total
|
$
|
210,134
|
(000's
omitted)
|
||||
|
||||
Trademarks
|
$
|
200,000
|
||
License
agreements
|
5,100
|
|||
Non-compete
agreement
|
3,000
|
|||
Goodwill
|
2,034
|
|||
Total
allocated purchase price
|
$
|
210,134
|
(000's
omitted except share information)
|
|
|
|||||||||||
|
Three
Months Ended June 30,
|
Six
Months Ended June 30,
|
|||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Licensing
revenues
|
$
|
39,071
|
$
|
38,092
|
$
|
82,698
|
$
|
73,808
|
|||||
Operating
income
|
$
|
29,729
|
$
|
18,928
|
$
|
61,177
|
$
|
34,817
|
|||||
Net
income
|
$
|
14,789
|
$
|
7,232
|
$
|
30,850
|
$
|
13,725
|
|||||
|
|||||||||||||
Basic
earnings per common share
|
$
|
0.26
|
$
|
0.17
|
$
|
0.55
|
$
|
0.32
|
|||||
Diluted
earnings per common share
|
$
|
0.24
|
$
|
0.15
|
$
|
0.50
|
$
|
0.28
|
|
Total
|
2007
|
2008
|
2009
|
2010
|
2011
|
thereafter
|
|||||||||||||||
Due
to Sweet (Note J)
|
$
|
3,230
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
3,230
|
$
|
-
|
||||||||
Kmart
Note
|
3,781
|
3,781
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||
Asset
backed notes
|
147,072
|
19,553
|
21,300
|
23,202
|
25,275
|
27,533
|
30,209
|
|||||||||||||||
Term
Loan Facility
|
211,969
|
2,125
|
2,125
|
2,125
|
2,125
|
2,125
|
201,344
|
|||||||||||||||
Convertible
Notes
|
281,067
|
-
|
-
|
-
|
-
|
-
|
281,067
|
|||||||||||||||
Total
Debt
|
$
|
647,119
|
$
|
25,459
|
$
|
23,425
|
$
|
25,327
|
$
|
27,400
|
$
|
32,888
|
$
|
512,620
|
|
Six
months ended
|
|||
|
June
30,
|
|||
|
2007
|
|||
Expected
Volatility
|
.30-.50
|
|||
Expected
Dividend Yield
|
0%
|
|
||
Expected
Life (Term)
|
3-5
years
|
|||
Risk-Free
Interest Rate
|
3.00-4.75%
|
|
|
Weighted-Average
|
||||||
|
Options
|
Exercise
Price
|
|||||
Outstanding
January 1, 2007
|
5,769,632
|
$
|
4.35
|
||||
Granted
|
-
|
-
|
|||||
Canceled
|
-
|
-
|
|||||
Exercised
|
(199,750
|
)
|
5.40
|
||||
Expired
|
-
|
-
|
|||||
Outstanding
June 30, 2007
|
5,569,882
|
$
|
4.31
|
||||
Exercisable
at June 30, 2007
|
5,482,714
|
$
|
4.23
|
|
Weighted-Average
|
||||||
Warrants
|
Exercise
Price
|
||||||
Outstanding
January 1, 2007
|
799,175
|
$
|
11.02
|
||||
Granted
in connection with Sold Warrants (see Note E)
|
3,628,450
|
42.40
|
|||||
Granted
|
80,000
|
20.32
|
|||||
Canceled
|
-
|
-
|
|||||
Exercised
|
(655,750
|
)
|
11.52
|
||||
Expired
|
-
|
-
|
|||||
Outstanding
June 30, 2007
|
3,851,875
|
$
|
40.69
|
||||
Exercisable
at June 30, 2007
|
158,425
|
$
|
14.58
|
·
|
could
impair our liquidity;
|
·
|
could
make it more difficult for us to satisfy our other
obligations;
|
·
|
require
us to dedicate a substantial portion of our cash flow to payments
on our
debt obligations, which reduces the availability of our cash flow
to fund
working capital, capital expenditures and other corporate
requirements;
|
·
|
could
impede us from obtaining additional financing in the future for working
capital, capital expenditures, acquisitions and general corporate
purposes;
|
·
|
impose
restrictions on us with respect to future
acquisitions;
|
·
|
make
us more vulnerable in the event of a downturn in our business prospects
and could limit our flexibility to plan for, or react to, changes
in our
licensing markets; and
|
·
|
place
us at a competitive disadvantage when compared to our competitors
who have
less debt.
|
Exhibit
No.
|
|
Description
of Exhibit
|
|
|
|
Exhibit
3(ii)**
|
|
By-laws,
as amended.
|
|
|
|
Exhibit
4.1(1)
|
|
Indenture,
dated June 20, 2007, between Iconix Brand Group, Inc. and The Bank
of New
York.
|
|
|
|
Exhibit
4.2(1)
|
|
Registration
Rights Agreement, dated June 20, 2007, among Iconix Brand Group,
Inc.,
Merrill Lynch Pierce, Fenner & Smith, Incorporated & Lehman
Brothers Inc.
|
|
|
|
Exhibit
10.1(2)*
|
|
Amended
and Restated Credit Agreement dated as of May 2, 2007 by and among
Iconix
brand Group, Inc., Lehman Brothers Inc., as Arranger, and Lehman
Commercial Paper Inc., as Lender, as Syndication Agent and as
Administrative Agent.
|
|
|
|
Exhibit
10.2(2)*
|
|
Guarantee
and Collateral Agreement made by Iconix Brand Group, Inc, and certain
of
its subsidiaries in favor of Lehman Commercial Paper Inc., as
Administrative Agent.
|
|
|
|
Exhibit
10.3(1)
|
|
Purchase
Agreement, dated June 14, 2007, by and among Iconix Brand Group,
Inc., Merrill Lynch Pierce, Fenner & Smith, Incorporated & Lehman
Brothers Inc.
|
|
|
|
Exhibit
10.4(1)
|
|
Letter
Agreement Confirming OTC Convertible Note Hedge, dated June 19, 2007,
among Iconix Brand Group, Inc., Merrill Lynch International and,
solely in
its capacity as agent thereunder, Merrill Lynch, Pierce, Fenner &
Smith Incorporated.
|
|
|
|
Exhibit
10.5(1)
|
|
Letter
Agreement, Confirming OTC Convertible Note Hedge, dated June 19,
2007,
among Iconix Brand Group, Inc., , Lehman Brothers OTC Derivatives
Inc.
and, solely in its capacity as agent thereunder, Lehman
Brothers.
|
|
|
|
Exhibit
10.6(1)
|
|
Letter
Agreement, Confirming OTC Warrant Transaction, dated June 19, 2007,
among
Iconix Brand Group, Inc., Merrill Lynch International and, solely
in its
capacity as agent thereunder, Merrill Lynch, Pierce, Fenner & Smith
Incorporated.
|
|
|
|
Exhibit
10.7(1)
|
|
Letter
Agreement, Confirming OTC Warrant Transaction, dated June 19, 2007,
among
Iconix Brand Group, Inc., Lehman Brothers OTC Derivatives Inc. and,
solely
in its capacity as agent thereunder, Lehman Brothers
|
Exhibit 31.1 | Certification of Chief Executive Officer Pursuant To Rule 13a-14 or 15d-14 of The Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act of 2002. | |
Exhibit 31.2 | Certification of Chief Financial Officer Pursuant To Rule 13a-14 or 15d-14 of The Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act of 2002. | |
Exhibit 32.1 | Certification of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of The Sarbanes-Oxley Act of 2002. | |
Exhibit 32.2 | Certification of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of The Sarbanes-Oxley Act of 2002. |
*
|
Iconix
Brand Group, Inc. has omitted certain schedules and exhibits pursuant
to
Item 601(b)(2) of Regulation S-K and shall furnish supplementally
to the
SEC copies of any of the omitted schedules and exhibits upon request
by
the SEC.
|
**
|
Previously filed in Form 10-Q on August 8, 2007 |
Iconix
Brand Group, Inc.
(Registrant)
|
||
|
|
|
Date:
September 24, 2007
|
/s/
Neil Cole
|
|
Neil
Cole
Chairman
of the Board, President
and
Chief Executive Officer
(on
Behalf of the
Registrant)
|
|
|
|
Date:
September 24, 2007
|
/s/
Warren
Clamen
|
|
Warren
Clamen
Chief
Financial Officer
|